C10H15NO
165.23 g/mol
의약 중간체경고
(S)-3-(1-(dimethylamino)ethyl)phenol
CAS139306-10-8
용도 분류
의약 중간체
화합물 분류
아민
주요 용도
의약 중간체
This compound is a pharmaceutical intermediate used in the synthesis of active pharmaceutical ingredients. It features a phenolic hydroxyl group and a dimethylaminoethyl side chain with defined stereochemistry.
pharmaceutical intermediateresearch compound for organic synthesis
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 139306-10-8
관련 화합물
강한 관련동일 모체 구조
(S)-3-(1-(Dimethylamino)ethyl)phenol hydrochloride
CAS894079-56-2
research compound
참고동일 카테고리
1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azapentadecan-15-oic acid
CAS139338-72-0
Pharmaceutical intermediate for PEGylated compounds
참고동일 카테고리
5-Bromo-2-(trifluoromethoxy)benzyl chloride
CAS1393442-60-8
Pharmaceutical intermediate
참고동일 카테고리
5-Acetyl-6-hydroxypicolinaldehyde
CAS1393557-72-6
pharmaceutical intermediate
참고동일 카테고리
2-[(3R,5R)-3,5-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]cyclohexylidene]ethanol
CAS139356-37-9
Pharmaceutical intermediate
참고stereoisomer of
3-(1-(Dimethylamino)ethyl)phenol hydrochloride
CAS5441-61-2
research compound
참고stereoisomer of
(R)-3-(1-(DIMETHYLAMINO)ETHYL)PHENOL
CAS851086-95-8
Pharmaceutical intermediate for rivastigmine synthesis
참고stereoisomer of
3-(1-DIMETHYLAMINOETHYL)PHENOL
CAS105601-04-5
Rivastigmine intermediate
안전 참조
경고
H315Causes skin irritation
H317May cause an allergic skin reaction
H319Causes serious eye irritation
H335May cause respiratory irritation
식별자
IUPAC 이름
3-[(1S)-1-(dimethylamino)ethyl]phenol
InChIKey
GQZXRLWUYONVCP-QMMMGPOBSA-N
SMILES
C[C@@H](C1=CC(=CC=C1)O)N(C)C
동의어 목록 (19)
- SAF
- RIVASTIGMINE HYDROGEN TARTRATE IMPURITY A (EP IMPURITY)
- RIVASTIGMINE IMPURITY A (EP IMPURITY)
- RIVASTIGMINE TARTRATE IMPURITY, PHENOL IMPURITY-(USP IMPURITY)
- Rivastigmine EP impurity A
- Rivastigmine tartrate impurity, phenol impurity-(USP)
- 1gqs
- NAP 226-90
- RIVASTIGMINE IMPURITY A
- RIVASTIGMINE METABOLITE